Adjective:

বাতরোগের বৈশিষ্ট্যযুক্ত,

rheumatoid's Usage Examples:

joint disease) and rheumatoid arthritis.

Graves' disease, inflammatory bowel disease, multiple sclerosis, psoriasis, rheumatoid arthritis, and systemic lupus erythematosus.

Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn's disease.

moderate to severe rheumatoid arthritis.

The biologic agent rituximab (anti-B cell therapy) is now licensed for use in refractory rheumatoid arthritis.

atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form.

"Herbal therapy for treating rheumatoid arthritis".

significantly from forms of arthritis commonly seen in adults (osteoarthritis, rheumatoid arthritis), in terms of cause, disease associations, and prognosis.

under the brand name Jyseleca, is a medication used for the treatment of rheumatoid arthritis (RA).

Some typical connective tissue diseases such as rheumatoid arthritis, ankylosing spondylitis, SLE and scleroderma Other diseases.

under the brand name Humira, among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease.

Caplan's syndrome (or Caplan disease or rheumatoid pneumoconiosis) is a combination of rheumatoid arthritis (RA) and pneumoconiosis that manifests as.

Regeneron Pharmaceuticals and Sanofi developed the drug for the treatment of rheumatoid arthritis (RA), for which it received US FDA approval on 22 May 2017 and.

comprise a category of otherwise unrelated drugs defined by their use in rheumatoid arthritis to slow down disease progression.

Rheumatoid factor (RF) is the autoantibody that was first found in rheumatoid arthritis.

treatment of rheumatoid arthritis but was never marketed.

The drug produced estrogenic effects but failed to show effectiveness for rheumatoid arthritis.

application in the treatment of cancer and inflammatory diseases such as rheumatoid arthritis.

the brand name Olumiant among others, is a drug for the treatment of rheumatoid arthritis (RA) in adults whose disease was not well controlled using RA.

as an investigational drug for the treatment of rheumatoid arthritis Mavrilimumab has been studied in a phase 1 dose-ranging trial.

Synonyms:

arthritic; rheumatic; creaky; unhealthy; rheumy;

Antonyms:

illness; robust; unwellness; dry; healthy;